| FAFGX | NGDAX | FAFGX / NGDAX | |
| Total Expense Ratio | 0.38 | 1.02 | 37% |
| Annual Report Gross Expense Ratio | 0.38 | 1.02 | 37% |
| Fund Existence | 5 years | 17 years | - |
| Gain YTD | -0.984 | -2.460 | 40% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 336B | 2.56B | 13,146% |
| Annual Yield % from dividends | 0.47 | 0.00 | - |
| Returns for 1 year | 2.98 | -3.68 | -81% |
| Returns for 3 years | 46.04 | 36.91 | 125% |
| Returns for 5 years | 15.28 | 17.50 | 87% |
| Returns for 10 years | N/A | 81.71 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MOORX | 17.30 | 0.06 | +0.35% |
| MassMutual Small Cap Opps R4 | |||
| VSFSX | 26.70 | 0.08 | +0.30% |
| Federated Hermes MDT Small Cap Value R6 | |||
| JFNNX | 81.67 | -0.52 | -0.63% |
| Janus Henderson Global Life Sciences N | |||
| UPAAX | 18.41 | -0.30 | -1.60% |
| Upright Assets Allocation Plus | |||
| IRLAX | 81.97 | -1.49 | -1.79% |
| Voya Russell Large Cap Growth Idx Port A | |||